                </a></li></ul></div><p><strong>Figure 8.  <span>NF-κB binds to the <em>PIK3CA</em> promoter and activates its expression.</span></strong></p><a id="article1.body1.sec3.sec4.fig1.caption1.p1" name="article1.body1.sec3.sec4.fig1.caption1.p1"></a><p>A. Illustration of the predicted NF-κB binding site in human (top) or murine (bottom) <em>PIK3CA</em> promoter region. B. Illustration of the constructs comprising luciferase linked to the human <em>PIK3CA</em> promoter with (Luc-2340/316) or without the NF-κB binding site (Luc-378/316). C. Summary of luciferase activities of Luc-2340/316 and Luc-378/316 co-transfected with pCMV- IκBα or pCMV- IκBαM. D. Gelshift assay using ovarian cancer cell nuclear extract after TNF-α stimulation. <span class="underline">Lane 1</span>, NF-κB binding site of wild-type human <em>PIK3CA</em> promoter (wt hu<em>PIK3CA</em> NF-κB probe) alone; <span class="underline">lanes 2 and 3</span>, wt hu<em>PIK3CA</em> NF-κB probe+nuclear extract; <span class="underline">lane 4</span>, control NF-κB probe+nuclear extract, <span class="underline">lanes 5 and 6</span>, mutated hu<em>PIK3CA</em> NF-κB probe+nuclear extract; <span class="underline">lane 7</span>, mutated control NF-κB probe+nuclear extract; <span class="underline">lanes 8 and 9</span>, scramble hu<em>PIK3CA</em> NF-κB probe+nuclear extract. E. Gel shift assay using recombinant NF-κB/p50 protein. <span class="underline">Lane 1</span>, wt hu<em>PIK3CA</em> NF-κB probe alone; <span class="underline">lanes 2 and 3</span>, wt hu<em>PIK3CA</em> NF-κB probe+p50; <span class="underline">lane 4</span>, mutated hu<em>PIK3CA</em> NF-κB probe alone; <span class="underline">lanes 5 and 6</span>, mutated hu<em>PIK3CA</em> NF-κB probe+p50; <span class="underline">lane 7</span>, control NF-κB probe alone; <span class="underline">lanes 8 and 9</span>, control NF-κB probe+p50.</p>
<span>THISISTHEEND
